Za. Abassi et al., PULMONARY AND RENAL NEUTRAL ENDOPEPTIDASE EC-3.4.24.11 IN RATS WITH EXPERIMENTAL HEART-FAILURE, Hypertension, 25(6), 1995, pp. 1178-1184
Congestive heart failure is characterized by avid sodium retention and
a blunted renal response to exogenous and endogenous atrial natriuret
ic peptide. Inhibition of neutral endopeptidase EC 3.4.24.11, the main
enzyme that degrades natriuretic peptides, produces a natriuretic res
ponse in different models of congestive heart failure. This raises the
possibility that an increase in either the expression or activity of
neutral endopeptidase is responsible for these phenomena. In the prese
nt study, we examined (1) the renal effects of SQ-28,603, a neutral en
dopeptidase inhibitor, in rats with moderate and severe congestive hea
rt failure induced by an aortocaval fistula compared with sham control
s, and (2) neutral endopeptidase expression and activity in the lungs
and kidneys of these rats. Infusion of SQ-28,603 (40 mg/kg IV) induced
a significant natriuretic response in normal rats and rats with moder
ate congestive heart failure. This response was blunted in rats with s
evere congestive heart failure. Surprisingly, renal neutral endopeptid
ase mRNA levels, assessed by quantitative reverse transcriptase-polyme
rase chain reaction; protein levels, assessed by Western blotting; and
activity, assessed by gelatin gels, were comparable in all groups. Pu
lmonary neutral endopeptidase mRNA levels decreased by 45% in rats wit
h severe congestive heart failure but not in rats with mild congestive
heart failure. In addition, pulmonary neutral endopeptidase immunorea
ctivity levels and activity were significantly decreased in congestive
heart failure in correlation with the severity of the disorder. We co
nclude that an increase in neutral endopeptidase expression or activit
y does not occur in rats with congestive heart failure, and therefore,
an upregulation of neutral endopeptidase is unlikely to account for t
he blunted natriuretic response to the atrial natriuretic peptide and
the positive sodium balance in congestive heart failure.